Home » Healthcare » Pharmaceuticals » Compounding Pharmacies Market

Compounding Pharmacies Market By Type of Compounding (Non-Sterile Compounding, Sterile Compounding) By End-User (Patients, Hospitals and Healthcare Facilities, Veterinary Compounding) -Growth, Future Prospects & Competitive Analysis, 2022 – 2030

Published: | Report ID: 22848 | Report Format : PDF

Market Insights

  • The global demand for Compounding Pharmacies was valued at USD 13154.8million in 2022 and is expected to reach USD 20188.4 Million in 2030, growing at a CAGR of 5.50% between 2023 and 2030.
  • The sterility sector had the largest market share in 2022, and non-sterility can cover therapeutic gaps where commercially available medications do not meet specific patient demands.
  • The Hospitals and Healthcare Facilities sector is the fastest growing in the Compounding Pharmacies market, while the Patients category is the second largest in the Compounding Pharmacies industry.
  • The pain management category dominated the market in 2022, accounting for 33.1% of total revenue, while the nutritional supplements category is predicted to grow at the quickest rate throughout the forecast period.
  • The Compounding Pharmacies market is dominated by the Regulated Compounding sector. Less Regulated Compounding is predicted to grow at a CAGR during the projection period.
  • North America held the most share (43.56%) in 2022, and the Asia Pacific Compounding Pharmacies Market is predicted to grow at the quickest CAGR.
  • Market expansion is being driven by an aging population and Chronis disease.
  • Market expansion is hampered by a lack of clinical evidence and a fragmented market.

Executive Summary

Market Definition

The Compounding Pharmacies Market refers to the industry of pharmacies that specialize in the creation of personalized pharmaceuticals. These treatments are customized to satisfy the special needs of individual patients, such as specific dosages, flavours, or alternate formats. Compounding pharmacies serve an important role in offering individualized therapies and are frequently used in hospitals, healthcare facilities, and by patients who seek customized pharmaceuticals.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Market Overview

It is anticipated that between 2023 and 2030, the worldwide Compounding Pharmacies Market will expand at a compound annual growth rate (CAGR) of 5.50%. From USD 13154.8 million in 2022, the market is projected to be worth USD 20188.4 million by 2030.

The Compounding Pharmacies Market is a fast-growing business that meets the rising need for customized drugs. These pharmacies specialize in customizing pharmaceuticals to match the specific needs of their patients, such as personalized dosages, flavours, or alternate forms of medication. Compounded drugs are frequently used in hospitals and healthcare facilities, as well as by individuals requiring specialist therapies. Factors such as rising patient demand for tailored treatments, developments in pharmaceutical compounding techniques, and the rising frequency of chronic diseases are driving the market. It is a competitive business, with certified compounding pharmacies having a substantial proportion because to its high quality standards and restrictions. The market is likely to expand further as the demand for customized drugs grows and healthcare providers acknowledge the benefits of tailored treatments.

Segmentation By Type of Compounding

  • In 2022, the sterility sector held the biggest market share of 58.52%. It is predicted to increase at the fastest rate during the projection period. The increased demand for sterile-compounded pharmaceuticals in various healthcare settings is driving the segment’s rise.
  • Non-sterility can fill therapeutic gaps where commercially accessible drugs do not fulfill specific patient demands.

Segmentation By End-User

  • The Hospitals and Healthcare Facilities sector is the fastest growing in the Compounding Pharmacies market. This is due to the growing demand for personalized drugs to satisfy the specific needs of hospitalized patients.
  • The Patients category is the Compounding Pharmacies market’s second largest segment.

Segmentation by Medication Type

  • In 2022, the pain management category dominated the market, accounting for 33.1% of total revenue. The increased prevalence of chronic pain and the negative effects associated with commercially accessible pain management drugs can be ascribed to the segment’s high share.
  • The nutritional supplements category is expected to develop at the fastest rate throughout the forecast period. This is due to the increasing desire for tailored cosmetic and anti-aging solutions.

Segmentation by Regulatory Environment

  • The Regulated Compounding sector holds the largest proportion of the Compounding Pharmacies market. Because of its adherence to tight norms and quality standards set by regulatory agencies, this segment influences market demand.
  • Over the projection period, the Less Regulated Compounding is expected to increase at a CAGR.

Segmentation by Region

  • In 2022, North America held the greatest share (43.56%).
  • The Asia Pacific Compounding Pharmacies Market is expected to expand at the fastest CAGR.
  • The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for Compounding Pharmacies.

Over the projection period, North America is expected to have the biggest market share. The presence of multiple compounding pharmacies, high consumer adoption, and the scarcity of particular pharmaceuticals are all important drivers of industry growth. The United States Food and Drug Administration (FDA) has laws in place to ensure the quality of medicines. Furthermore, each state has its own set of laws and regulations controlling the operation of a compounding pharmacy. As a result, these rules help to build patients’ trust in compounding pharmacies and are expected to increase demand for them over the forecast period.

Over the forecast period, Asia Pacific is expected to increase at the fastest rate. As healthcare practitioners and patients appreciate the value of personalized healthcare solutions, the notion of personalized medicine is gaining ground throughout the Asia Pacific area. Compounding pharmacies are essential in providing individualized drugs and satisfying the specific needs of patients who require customized dosages, formulations, and delivery modalities. Furthermore, advancements in pharmaceutical science and technology are helping to expand compounding pharmacy services across the Asia Pacific region. These improvements allow compounding pharmacies to manufacture novel and effective drugs for individuals with a wide range of healthcare needs. As a result, the market in the region is expanding.

Key Highlights of the Report

The global Compounding Pharmacies Market is segmented By Type of Compounding, Product Form, Medication Type, Regulatory Environment, and region. The sterility and Regulated Compounding sector has the largest market share. Furthermore, the Hospitals and Healthcare Facilities sector is the fastest growing in the Compounding Pharmacies market, and Less Regulated Compounding is predicted to develop at a CAGR, with North America leading the market growth.

The primary drivers of the market are rising demand for tailored treatments, advancements in pharmaceutical compounding procedures, and the rising prevalence of chronic diseases. Furthermore, the significant hurdles in the market are stringent regulatory requirements, limited insurance coverage for compounded drugs, and difficulties in maintaining quality control and standardization.

Nonetheless, North America is predicted to have the largest market share. The presence of several compounding pharmacies, high customer acceptance, and the scarcity of specific medications are all major drivers of industry growth. Furthermore, Asia Pacific is predicted to grow the fastest. As healthcare practitioners and people see the value of individualized healthcare solutions, the concept of personalized medicine is gaining traction throughout Asia Pacific.

What Elements Are Driving the Global Market for Compounding Pharmacies?

Several reasons are driving the Compounding Pharmacies Market. Personalized drugs are becoming increasingly popular. Patients want therapies that are tailored to their unique needs, such as customized dosages or alternate kinds of medication. Furthermore, developments in pharmaceutical compounding procedures are adding to the market’s growth. Compounding pharmacies may now manufacture drugs more efficiently and accurately thanks to these improvements. Furthermore, the increased frequency of chronic diseases is boosting demand for compounded pharmaceuticals, as patients require specific treatments to adequately manage their symptoms.

What Are The Main Obstacles That The Global Compounding Pharmacies Market Faces?

While the Compounding Pharmacies Market is expanding, there are certain factors to consider. Compounding pharmacies have difficulties due of stringent regulatory regulations. To guarantee patient safety and efficacy, they must adhere to stringent quality standards and laws. Furthermore, restricted insurance coverage for compounded pharmaceuticals may stymie industry expansion. Insurance companies may impose limits or limitations on coverage for personalized drugs, limiting their availability to some patients. Furthermore, because compounding pharmacies must assure uniformity in medicine manufacture, maintaining quality control and standardization can be difficult.

What Market Development Prospects Are There For Compounding Pharmacies Globally?

The Compounding Pharmacies Market offers numerous growth potential. Compounding pharmacies will benefit greatly from the expanding senior population. Because of their particular health needs, elderly people frequently require tailored drugs, making them an important population for compounding services. There is also room for growth in emerging markets. Compounding services are projected to increase in demand in these regions as healthcare infrastructure improves and knowledge of tailored therapies grows. Moreover, cooperation and partnerships with healthcare providers and pharmaceutical firms might open up new doors for compounding pharmacies. They can improve patient care and broaden their market reach by collaborating.

Market Drivers

The global Compounding Pharmacies Market is driven by several factors. The following are the key drivers of the global Compounding Pharmacies Market:

Ageing Population And Chronis Disease

The global incidence of chronic illnesses such as diabetes, cardiovascular disease, and arthritis is increasing, particularly as the population ages. Compounding pharmacies play an important role in chronic disease management by developing tailored drugs that suit the individual needs of patients with these disorders.

For instance, according to UICC data, the global population is rapidly aging. Currently, more than 703 million people worldwide are above the age of 65, accounting for 9.1% of the global population. According to predictions, this number will rise to 15.9% (1.5 billion people) by 2050. Similarly, according to World Health Organization data, more than half of cancer patients are 65 or older. This is most likely due to the accumulation of age-related risk factors for some malignancies and weakened cellular repair mechanisms. As a result, the facts mentioned above encourage market expansion over the predicted period.

Increasing Adoption For Pediatric And Geriatric Care

Compound drugs are particularly useful in pediatric and geriatric care. Children and the elderly may have difficulties swallowing tablets or require dosages and formulations that are appropriate for their age. To increase patient compliance and treatment outcomes, compounding pharmacies can manufacture drugs in alternative dosage forms and add flavours. As a result, rising acceptance of pediatric and geriatric patient care is likely to fuel market growth throughout the forecast period.

Market Restraints

The global Compounding Pharmacies Market faces some challenges that may hinder its growth. These include the following:

Limited Clinical Evidence And A Fragmented Market

The compounding pharmacy industry is usually fragmented, with many independent, small-scale pharmacies competing against larger, institutional pharmacies. Because of this fragmentation, compounding pharmacies’ procedures, quality standards, and patient experiences may differ. Furthermore, compounded drugs may have little clinical data supporting their safety and efficacy when compared to regular pharmaceuticals. The lack of solid clinical studies and thorough research data can stymie wider acceptance among healthcare providers and patients. As a result, market growth is estimated to be hampered over the forecast period.

Opportunities

The global Compounding Pharmacies Market offers significant growth opportunities. These include the following:

Growing Collaboration

Over the forecast period, increased collaboration among industry participants is expected to provide a lucrative opportunity for market growth. For example, Wedgewood Pharmacy of Loveland, Colorado, bought Front Range Laboratories (FRL), a full-service testing facility that has been a reliable partner of compounding pharmacies for more than 25 years, in February 2023. FRL provides analytical, microbiological, and other testing services, as well as product stability and other services, to suit the testing needs of pharmacies across the country. FRL’s founders, Michael Travis and Jennifer Travis, will continue to work for the company and be affiliated with Wedgewood Pharmacy. The FRL brand, which is well-known in the compounding pharmacy sector for providing high-quality services, will be kept by wedgewood pharmacy.

Competitive Landscape

Key Players

The global Compounding Pharmacies Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

  • Galderma S.A.
  • Allergan PLC
  • Merz Pharma
  • Laboratory ObvieLine
  • Bausch Health Companies Inc.
  • La Roche-Posay
  • IMAGE SKINCARE
  • Glytone
  • Lasermed
  • SciVision Biotech Inc.

These organizations prioritize product innovation, Disease Area expansion, and mergers and acquisitions to stay competitive.

The global Compounding Pharmacies Market’s key players continually seek to stay ahead by offering new Speciess and developments.

In July 2022, Fagron purchased a 503B outsourcing facility in Boston from Fresenius Kabi. Fagron increased its sterile compounding footprint in the United States.

In March 2022, Fresenius Kabi purchased a significant share in mAbxience, greatly increasing Fresenius Kabi’s foothold in the high-growth biopharmaceuticals industry.

In February 2023, Harrow announced the availability of next-generation compounded atropine formulations free of boric acid and preservatives. The fresh formulations can also be stored at room temperature for up to 180 days and have a physiological pH of 5.5. ImprimisRx, Harrow’s fully-owned compounding and mail-order pharmacy business, is currently offering the patent-pending formulations.

In July 2023, Osceola Capital announced the seventeenth and eighteenth improvements to the Revelation Pharma platform, offering the company a significant boost in size and capabilities. Revelation purchased both the Eagle Pharmacy in Hoover, Alabama, and the Lee Silsby Compounding Pharmacy in Beachwood, Ohio. Eagle, a 503B outsourced compounding pharmacy, provides services to healthcare facilities and prescribers in the United States.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Summary of Key Findings

  • Limited clinical data and a fragmented market stymie market expansion.
  • Market segmented By Type of Compounding, Product Form, Medication Type, Regulatory Environment, Protection Rating, Customization and Accessories and region
  • The Hospitals and Healthcare Facilities sector is the fastest growing in the Compounding Pharmacies market,
  • The pain management category dominated the market in 2022
  • North America is leading market growth; the market is highly competitive with key players including Galderma S.A., Allergan PLC, Merz Pharma, Laboratory ObvieLine, Bausch Health Companies Inc., La Roche-Posay, IMAGE SKINCARE, Glytone, Lasermed, SciVision Biotech Inc.

Future Outlook

  • Compounded drugs are becoming more popular.
  • Compounding process technological developments
  • Compounding services are expanding in emerging nations because to rising demand for individualized healthcare.
  • An increase in the prevalence of chronic diseases
  • Emphasis on quality control and standardization
  • Collaborations and collaborations with healthcare providers and pharmaceutical firms
  • Strict regulatory standards and compliance methods
  • Compounding pharmacy integration with digital healthcare platforms
  • Better patient care and medication adherence

Segmentation

By Type of Compounding:

  • Non-Sterile Compounding
  • Sterile Compounding

By End-User:

  • Patients
  • Hospitals and Healthcare Facilities
  • Veterinary Compounding

By Medication Type:

  • Hormone Replacement Therapy (HRT)
  • Pain Management
  • Dermatological Compounds
  • Pediatric Compounding
  • Nutritional Supplements
  • Specialty Medications

By Regulatory Environment:

  • Regulated Compounding
  • Less Regulated Compounding
  • By Region
    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East and Africa

Adjacent Markets

In the Compounding Pharmacies Market, there are several adjacent markets which has high revenue growth opportunities. The key adjacent markets for Compounding Pharmacies Market-

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction

2. Executive Summary
2.1. Market Snapshot: Global Compounding Pharmacies Market
2.1.1. Global Compounding Pharmacies Market, By Type of Compounding
2.1.2. Global Compounding Pharmacies Market, By End-User
2.1.3. Global Compounding Pharmacies Market, By Medication Type
2.1.4. Global Compounding Pharmacies Market, By Regulatory Environment
2.1.5. Global Compounding Pharmacies Market, By Region
2.2. Insights from Primary Respondents

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Compounding Pharmacies Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Compounding Pharmacies Market Drivers
3.2.2. Compounding Pharmacies Market Restraints
3.2.3. Compounding Pharmacies Market Opportunities
3.2.4. Major Compounding Pharmacies Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type of Compounding
3.5.2. End-User
3.5.3. Medication Type
3.5.4. Regulatory Environment
3.5.5. Sales Channel
3.5.6. Price Range
3.5.7. Geography

4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global Compounding Pharmacies Market: Company Market Share, Value 2022
4.1.2. Global Compounding Pharmacies Market: Top 6 Company Market Share, Value 2022
4.1.3. Global Compounding Pharmacies Market: Top 3 Company Market Share, Value 2022
4.2. Global Compounding Pharmacies Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Type of Compounding Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Type of Compounding Matrix
4.7. Potential for New Players in the Global Compounding Pharmacies Market

5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. End-User Analysis
5.6.1. Pain Management in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis

6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Type of Compounding Launch
6.5.5. Geographical Expansion
6.5.6. Autoimmune Diseases

7. Impact Analysis of COVID 19 and Russia – Ukraine War on Compounding Pharmacies Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Type of Compounding Mix
7.2.4. Reduced Industrial Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa

8. Global Compounding Pharmacies Market, By Type of Compounding
8.1. Global Compounding Pharmacies Market Overview, By Type of Compounding
8.1.1. Global Compounding Pharmacies Market Revenue Share, By Type of Compounding, 2022 Vs 2030 (in %)
8.2. Non-Sterile Compounding
8.2.1. Global Compounding Pharmacies Market, By NON-STERILE COMPOUNDING, By Region, 2017-2030 (US$ Mn)
8.2.2. Market Dynamics for NON-STERILE COMPOUNDING
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Sterile Compounding
8.3.1. Global Compounding Pharmacies Market, By STERILE COMPOUNDING, By Region, 2017-2030 (US$ Mn)
8.3.2. Market Dynamics for STERILE COMPOUNDING
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends

9. Global Compounding Pharmacies Market, By End-User
9.1. Global Compounding Pharmacies Market Overview, By End-User
9.1.1. Global Compounding Pharmacies Market Revenue Share, By End-User, 2022 Vs 2030 (in %)
9.2. Patients
9.2.1. Global Compounding Pharmacies Market, By Patients, By Region, 2017-2030 (US$ Mn)
9.2.2. Market Dynamics for Patients
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Hospitals and Healthcare Facilities
9.3.1. Global Compounding Pharmacies Market, By Hospitals and Healthcare Facilities, By Region, 2017-2030 (US$ Mn)
9.3.2. Market Dynamics for Hospitals and Healthcare Facilities
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
9.4. Veterinary Compounding
9.4.1. Global Compounding Pharmacies Market, By Veterinary Compounding, By Region, 2017-2030 (US$ Mn)
9.4.2. Market Dynamics for Veterinary Compounding
9.4.2.1. Drivers
9.4.2.2. Restraints
9.4.2.3. Opportunities
9.4.2.4. Trends

10. Global Compounding Pharmacies Market, By Medication Type
10.1. Global Compounding Pharmacies Market Overview, By Medication Type
10.1.1. Global Compounding Pharmacies Market Revenue Share, By Medication Type, 2022 Vs 2030 (in %)
10.2. Hormone Replacement Therapy (HRT)
10.2.1. Global Compounding Pharmacies Market, By Hormone Replacement Therapy (HRT), By Region, 2017-2030 (US$ Mn)
10.2.2. Market Dynamics for Hormone Replacement Therapy (HRT)
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Pain Management
10.3.1. Global Compounding Pharmacies Market, By Pain Management, By Region, 2017-2030 (US$ Mn)
10.3.2. Market Dynamics for Pain Management
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
10.4. Dermatological Compounds
10.4.1. Global Compounding Pharmacies Market, Dermatological Compounds, By Region, 2017-2030 (US$ Mn)
10.4.2. Market Dynamics for Dermatological Compounds
10.4.2.1. Drivers
10.4.2.2. Restraints
10.4.2.3. Opportunities
10.4.2.4. Trends
10.5. Pediatric Compounding
10.5.1. Global Compounding Pharmacies Market, By Pediatric Compounding, By Region, 2017-2030 (US$ Mn)
10.5.2. Market Dynamics for Pediatric Compounding
10.5.2.1. Drivers
10.5.2.2. Restraints
10.5.2.3. Opportunities
10.5.2.4. Trends
10.6. Nutritional Supplements
10.6.1. Global Compounding Pharmacies Market, By Nutritional Supplements, By Region, 2017-2030 (US$ Mn)
10.6.2. Market Dynamics for Nutritional Supplements
10.6.2.1. Drivers
10.6.2.2. Restraints
10.6.2.3. Opportunities
10.6.2.4. Trends

1.1. Specialty Medications
1.1.1. Global Compounding Pharmacies Market, By Specialty Medications, By Region, 2017-2030 (US$ Mn)
1.1.2. Market Dynamics for Specialty Medications
1.1.2.1. Drivers
1.1.2.2. Restraints
1.1.2.3. Opportunities
1.1.2.4. Trends

2. Global Compounding Pharmacies Market, By Regulatory Environment
2.1. Global Compounding Pharmacies Market Overview, by Regulatory Environment
2.1.1. Global Compounding Pharmacies Market Revenue Share, By Regulatory Environment, 2022 Vs 2030 (in %)
2.2. Regulated Compounding
2.2.1. Global Compounding Pharmacies Market, By Regulated Compounding, By Region, 2017-2030 (US$ Mn)
2.2.2. Market Dynamics for Regulated Compounding
2.2.2.1. Drivers
2.2.2.2. Restraints
2.2.2.3. Opportunities
2.2.2.4. Trends
2.3. Less Regulated Compounding
2.3.1. Global Compounding Pharmacies Market, By Less Regulated Compounding, By Region, 2017-2030 (US$ Mn)
2.3.2. Market Dynamics for Less Regulated Compounding
2.3.2.1. Drivers
2.3.2.2. Restraints
2.3.2.3. Opportunities
2.3.2.4. Trends

3. Global Compounding Pharmacies Market, By Region
3.1. Global Compounding Pharmacies Market Overview, by Region
3.1.1. Global Compounding Pharmacies Market, By Region, 2022 vs 2030 (in%)
3.2. Type of Compounding
3.2.1. Global Compounding Pharmacies Market, By Type of Compounding, 2017-2030 (US$ Mn)
3.3. End-User
3.3.1. Global Compounding Pharmacies Market, By End-User, 2017-2030 (US$ Mn)
3.4. Medication Type
3.4.1. Global Compounding Pharmacies Market, By Medication Type, 2017-2030 (US$ Mn)
3.5. Regulatory Environment
3.5.1. Global Compounding Pharmacies Market, By Regulatory Environment, 2017-2030 (US$ Mn)

4. North AmericaCompounding Pharmacies Market Analysis
4.1. Overview
4.1.1. Market Dynamics for North America
4.1.1.1. Drivers
4.1.1.2. Restraints
4.1.1.3. Opportunities
4.1.1.4. Trends
4.2. North America Compounding Pharmacies Market, By Type of Compounding, 2017-2030(US$ Mn)
4.2.1. Overview
4.2.2. SRC Analysis
4.3. North America Compounding Pharmacies Market, By End-User, 2017-2030(US$ Mn)
4.3.1. Overview
4.3.2. SRC Analysis
4.4. North America Compounding Pharmacies Market, By Medication Type, 2017-2030(US$ Mn)
4.4.1. Overview
4.4.2. SRC Analysis
4.5. North America Compounding Pharmacies Market, By Regulatory Environment, 2017-2030(US$ Mn)
4.5.1. Overview
4.5.2. SRC Analysis
4.6. North America Compounding Pharmacies Market, by Country, 2017-2030(US$ Mn)
4.6.1. North America Compounding Pharmacies Market, by Country, 2022 Vs 2030 (in%)
4.6.2. U.S.
4.6.3. Canada
4.6.4. Mexico

5. Europe Compounding Pharmacies Market Analysis
5.1. Overview
5.1.1. Market Dynamics for North America
5.1.1.1. Drivers
5.1.1.2. Restraints
5.1.1.3. Opportunities
5.1.1.4. Trends
5.2. Europe Compounding Pharmacies Market, By Type of Compounding, 2017-2030(US$ Mn)
5.2.1. Overview
5.2.2. SRC Analysis
5.3. Europe Compounding Pharmacies Market, By End-User, 2017-2030(US$ Mn)
5.3.1. Overview
5.3.2. SRC Analysis
5.4. Europe Compounding Pharmacies Market, By Medication Type, 2017-2030(US$ Mn)
5.4.1. Overview
5.4.2. SRC Analysis
5.5. Europe Compounding Pharmacies Market, By Regulatory Environment, 2017-2030(US$ Mn)
5.5.1. Overview
5.5.2. SRC Analysis
5.6. Europe Compounding Pharmacies Market, by Country, 2017-2030 (US$ Mn)
5.6.1. Europe Compounding Pharmacies Market, by Country, 2022 Vs 2030 (in%)
5.6.2. UK
5.6.3. France
5.6.4. Germany
5.6.5. Italy
5.6.6. Spain
5.6.7. Benelux
5.6.8. Russia
5.6.9. Rest of Europe

6. Asia Pacific Compounding Pharmacies Market Analysis
6.1. Overview
6.1.1. Market Dynamics for North America
6.1.1.1. Drivers
6.1.1.2. Restraints
6.1.1.3. Opportunities
6.1.1.4. Trends
6.2. Asia Pacific Compounding Pharmacies Market, By Type of Compounding, 2017-2030(US$ Mn)
6.2.1. Overview
6.2.2. SRC Analysis
6.3. Asia Pacific Compounding Pharmacies Market, By End-User, 2017-2030(US$ Mn)
6.3.1. Overview
6.3.2. SRC Analysis
6.4. Asia Pacific Compounding Pharmacies Market, By Medication Type, 2017-2030(US$ Mn)
6.4.1. Overview
6.4.2. SRC Analysis
6.5. Asia Pacific Compounding Pharmacies Market, By Regulatory Environment, 2017-2030(US$ Mn)
6.5.1. Overview
6.5.2. SRC Analysis
6.6. Asia Pacific Compounding Pharmacies Market, by Country, 2017-2030 (US$ Mn)
6.6.1. Asia Pacific Compounding Pharmacies Market, by Country, 2022 Vs 2030 (in%)
6.6.2. China
6.6.3. Japan
6.6.4. India
6.6.5. South Korea
6.6.6. South East Asia
6.6.7. Rest of Asia Pacific

7. Latin America Compounding Pharmacies Market Analysis
7.1. Overview
7.1.1. Market Dynamics for North America
7.1.1.1. Drivers
7.1.1.2. Restraints
7.1.1.3. Opportunities
7.1.1.4. Trends
7.2. Latin America Compounding Pharmacies Market, By Type of Compounding, 2017-2030(US$ Mn)
7.2.1. Overview
7.2.2. SRC Analysis
7.3. Latin America Compounding Pharmacies Market, By End-User, 2017-2030(US$ Mn)
7.3.1. Overview
7.3.2. SRC Analysis
7.4. Latin America Compounding Pharmacies Market, By Medication Type, 2017-2030(US$ Mn)
7.4.1. Overview
7.4.2. SRC Analysis
7.5. Latin America Compounding Pharmacies Market, By Regulatory Environment, 2017-2030(US$ Mn)
7.5.1. Overview
7.5.2. SRC Analysis
7.6. Latin America Compounding Pharmacies Market, by Country, 2017-2030 (US$ Mn)
7.6.1. Latin America Compounding Pharmacies Market, by Country, 2022 Vs 2030 (in%)
7.6.2. Brazil
7.6.3. Argentina
7.6.4. Rest of Latin America

8. Middle East Compounding Pharmacies Market Analysis
8.1. Overview
8.1.1. Market Dynamics for North America
8.1.1.1. Drivers
8.1.1.2. Restraints
8.1.1.3. Opportunities
8.1.1.4. Trends
8.2. Middle East Compounding Pharmacies Market, By Type of Compounding, 2017-2030(US$ Mn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. Middle East Compounding Pharmacies Market, By End-User, 2017-2030(US$ Mn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. Middle East Compounding Pharmacies Market, By Medication Type, 2017-2030(US$ Mn)
8.4.1. Overview
8.4.2. SRC Analysis
8.5. Middle East Compounding Pharmacies Market, By Regulatory Environment, 2017-2030(US$ Mn)
8.5.1. Overview
8.5.2. SRC Analysis
8.6. Middle East Compounding Pharmacies Market, by Country, 2017-2030 (US$ Mn)
8.6.1. Middle East Compounding Pharmacies Market, by Country, 2022 Vs 2030 (in%)
8.6.2. UAE
8.6.3. Saudi Arabia
8.6.4. Rest of Middle East

9. Africa Compounding Pharmacies Market Analysis
9.1. Overview
9.1.1. Market Dynamics for North America
9.1.1.1. Drivers
9.1.1.2. Restraints
9.1.1.3. Opportunities
9.1.1.4. Trends
9.2. Africa Compounding Pharmacies Market, By Type of Compounding, 2017-2030(US$ Mn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Africa Compounding Pharmacies Market, By End-User, 2017-2030(US$ Mn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Africa Compounding Pharmacies Market, By Medication Type, 2017-2030(US$ Mn)
9.4.1. Overview
9.4.2. SRC Analysis
9.5. Africa Compounding Pharmacies Market, By Regulatory Environment, 2017-2030(US$ Mn)
9.5.1. Overview
9.5.2. SRC Analysis
9.6. Africa Compounding Pharmacies Market, by Country, 2017-2030 (US$ Mn)
9.6.1. Middle East Compounding Pharmacies Market, by Country, 2022 Vs 2030 (in%)
9.6.2. South Africa
9.6.3. Egypt
9.6.4. Rest of Africa

10. Company Profiles
10.1. Galderma S.A.
10.1.1. Company Overview
10.1.2. Type of Compoundings/Services Portfolio
10.1.3. Geographical Presence
10.1.4. SWOT Analysis
10.1.5. Financial Summary
10.1.5.1. Market Revenue and Net Profit (2019-2022)
10.1.5.2. Business Segment Revenue Analysis
10.1.5.3. Geographical Revenue Analysis
10.2. Allergan PLC
10.3. Merz Pharma
10.4. Laboratory ObvieLine
10.5. Bausch Health Companies Inc.
10.6. La Roche-Posay
10.7. IMAGE SKINCARE
10.8. Glytone
10.9. Lasermed
10.10. SciVision Biotech Inc.

11. Research Methodology
11.1. Research Methodology
11.2. Hormone Replacement Therapy (HRT) – Secondary Research
11.3. Hormone Replacement Therapy (HRT)I – Data Modelling
11.3.1. Company Share Analysis Model
11.3.2. Revenue Based Modelling
11.4. Hormone Replacement Therapy (HRT)II – Primary Research
11.5. Research Limitations
11.5.1. Assumptions

List of Figures
FIG. 1 Global Compounding Pharmacies Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Compounding Pharmacies Market Segmentation
FIG. 4 Global Compounding Pharmacies Market, By Type of Compounding, 2022 (US$ Mn)
FIG. 5 Global Compounding Pharmacies Market, By End-User, 2022 (US$ Mn)
FIG. 6 Global Compounding Pharmacies Market, By Medication Type, 2022 (US$ Mn)
FIG. 7 Global Compounding Pharmacies Market, by Regulatory Environment, 2022 (US$ Mn)
FIG. 8 Global Compounding Pharmacies Market, by Geography, 2022 (US$ Mn)
FIG. 9 Attractive Investment Proposition, By Type of Compounding, 2022
FIG. 10 Attractive Investment Proposition, By End-User, 2022
FIG. 11 Attractive Investment Proposition, By Medication Type, 2022
FIG. 12 Attractive Investment Proposition, By Regulatory Environment, 2022
FIG. 13 Attractive Investment Proposition, by Geography, 2022
FIG. 14 Global Market Share Analysis of Key Compounding Pharmacies Market Manufacturers, 2022
FIG. 15 Global Market Positioning of Key Compounding Pharmacies Market Manufacturers, 2022
FIG. 16 Global Compounding Pharmacies Market Value Contribution, By Type of Compounding, 2022 & 2030 (Value %)
FIG. 17 Global Compounding Pharmacies Market, by Non-Sterile Compounding, Value, 2017-2030 (US$ Mn)
FIG. 18 Global Compounding Pharmacies Market, by Sterile Compounding, Value, 2017-2030 (US$ Mn)
FIG. 19 Global Compounding Pharmacies Market Value Contribution, By End-User, 2022 & 2030 (Value %)
FIG. 20 Global Compounding Pharmacies Market, by Patients, Value, 2017-2030 (US$ Mn)
FIG. 21 Global Compounding Pharmacies Market, by Hospitals and Healthcare Facilities, Value, 2017-2030 (US$ Mn)
FIG. 22 Global Compounding Pharmacies Market, by Veterinary Compounding, Value, 2017-2030 (US$ Mn)
FIG. 23 Global Compounding Pharmacies Market Value Contribution, By Medication Type, 2022 & 2030 (Value %)
FIG. 24 Global Compounding Pharmacies Market, by Hormone Replacement Therapy (HRT), Value, 2017-2030 (US$ Mn)
FIG. 25 Global Compounding Pharmacies Market, by Pain Management, Value, 2017-2030 (US$ Mn)
FIG. 26 Global Compounding Pharmacies Market, by Dermatological Compounds, Value, 2017-2030 (US$ Mn)
FIG. 27 Global Compounding Pharmacies Market, by Pediatric Compounding, Value, 2017-2030 (US$ Mn)
FIG. 28 Global Compounding Pharmacies Market, by Nutritional Supplements, Value, 2017-2030 (US$ Mn)
FIG. 29 Global Compounding Pharmacies Market, by Specialty Medications, Value, 2017-2030 (US$ Mn)
FIG. 30 Global Compounding Pharmacies Market Value Contribution, By Regulatory Environment, 2022 & 2030 (Value %)
FIG. 31 Global Compounding Pharmacies Market, by Regulated Compounding, Value, 2017-2030 (US$ Mn)
FIG. 32 Global Compounding Pharmacies Market, by Less Regulated Compounding, Value, 2017-2030 (US$ Mn)
FIG. 33 North America Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 34 U.S. Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 35 Canada Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 36 MexicoCompounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 37 Europe Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 38 Germany Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 39 France Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 40 U.K. Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 41 Italy Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 42 Spain Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 43 BeneluxCompounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 44 RussiaCompounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 45 Rest of Europe Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 46 Asia Pacific Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 47 China Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 48 Japan Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 49 India Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 50 South Korea Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 51 South-East Asia Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 52 Rest of Asia Pacific Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 53 Latin America Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 54 Brazil Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 55 ArgentinaCompounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 56 Rest of Latin America Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 57 Middle East Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 58 UAECompounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 59 Saudi ArabiaCompounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 60 Rest of Middle East Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 61 AfricaCompounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 62 South Africa Compounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 63 EgyptCompounding Pharmacies Market, 2017-2030 (US$ Mn)
FIG. 64 Rest of Africa Compounding Pharmacies Market, 2017-2030 (US$ Mn)

 

List of Tables
TABLE 1 Market Snapshot: Global Compounding Pharmacies Market
TABLE 2 Global Compounding Pharmacies Market: Drivers Impact Analysis
TABLE 3 Global Compounding Pharmacies Market: Market Restraints Impact Analysis
TABLE 4 Global Compounding Pharmacies Market, by Competitive Benchmarking, 2022
TABLE 5 Global Compounding Pharmacies Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Compounding Pharmacies Market, by Key Strategies Analysis, 2022
TABLE 7 Global Compounding Pharmacies Market, by Non-Sterile Compounding, By Region, 2017-2022 (US$ Mn)
TABLE 8 Global Compounding Pharmacies Market, by Non-Sterile Compounding, By Region, 2023-2030 (US$ Mn)
TABLE 9 Global Compounding Pharmacies Market, by Sterile Compounding, By Region, 2017-2022 (US$ Mn)
TABLE 10 Global Compounding Pharmacies Market, by Sterile Compounding, By Region, 2023-2030 (US$ Mn)
TABLE 11 Global Compounding Pharmacies Market, by Patients, By Region, 2017-2022 (US$ Mn)
TABLE 12 Global Compounding Pharmacies Market, by Patients, By Region, 2023-2030 (US$ Mn)
TABLE 13 Global Compounding Pharmacies Market, by Hospitals and Healthcare Facilities, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global Compounding Pharmacies Market, by Hospitals and Healthcare Facilities, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global Compounding Pharmacies Market, by Veterinary Compounding, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global Compounding Pharmacies Market, by Veterinary Compounding, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global Compounding Pharmacies Market, by Hormone Replacement Therapy (HRT), By Region, 2017-2022 (US$ Mn)
TABLE 18 Global Compounding Pharmacies Market, by Hormone Replacement Therapy (HRT), By Region, 2023-2030 (US$ Mn)
TABLE 19 Global Compounding Pharmacies Market, by Pain Management, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global Compounding Pharmacies Market, by Pain Management, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global Compounding Pharmacies Market, by Dermatological Compounds, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global Compounding Pharmacies Market, by Dermatological Compounds, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global Compounding Pharmacies Market, by Pediatric Compounding, By Region, 2017-2022 (US$ Mn)
TABLE 24 Global Compounding Pharmacies Market, by Pediatric Compounding, By Region, 2023-2030 (US$ Mn)
TABLE 25 Global Compounding Pharmacies Market, by Nutritional Supplements, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global Compounding Pharmacies Market, by Nutritional Supplements, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global Compounding Pharmacies Market, by Specialty Medications, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global Compounding Pharmacies Market, by Specialty Medications, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global Compounding Pharmacies Market, by Regulated Compounding, By Region, 2017-2022 (US$ Mn)
TABLE 30 Global Compounding Pharmacies Market, by Regulated Compounding, By Region, 2023-2030 (US$ Mn)
TABLE 31 Global Compounding Pharmacies Market, by Less Regulated Compounding, By Region, 2017-2022 (US$ Mn)
TABLE 32 Global Compounding Pharmacies Market, by Less Regulated Compounding, By Region, 2023-2030 (US$ Mn)
TABLE 33 Global Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 34 Global Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 35 Global Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 36 Global Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 37 Global Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 38 Global Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 39 Global Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 40 Global Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 41 Global Compounding Pharmacies Market, by Region, 2017-2022 (US$ Mn)
TABLE 42 Global Compounding Pharmacies Market, by Region, 2023-2030 (US$ Mn)
TABLE 43 North America Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 44 North America Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 45 North America Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 46 North America Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 47 North America Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 48 North America Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 49 North America Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 50 North America Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 51 North America Compounding Pharmacies Market, by Country, 2017-2022 (US$ Mn)
TABLE 52 North America Compounding Pharmacies Market, by Country, 2023-2030 (US$ Mn)
TABLE 53 United States Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 54 United States Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 55 United States Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 56 United States Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 57 United States Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 58 United States Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 59 United States Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 60 United States Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 61 Canada Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 62 Canada Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 63 Canada Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 64 Canada Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 65 Canada Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 66 Canada Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 67 Canada Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 68 Canada Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 69 Mexico Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 70 Mexico Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 71 Mexico Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 72 Mexico Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 73 Mexico Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 74 Mexico Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 75 Mexico Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 76 Mexico Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 77 Europe Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 78 Europe Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 79 Europe Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 80 Europe Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 81 Europe Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 82 Europe Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 83 Europe Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 84 Europe Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 85 Europe Compounding Pharmacies Market, by Country, 2017-2022 (US$ Mn)
TABLE 86 Europe Compounding Pharmacies Market, by Country, 2023-2030 (US$ Mn)
TABLE 87 Germany Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 88 Germany Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 89 Germany Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 90 Germany Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 91 Germany Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 92 Germany Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 93 Germany Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 94 Germany Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 95 France Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 96 France Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 97 France Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 98 France Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 99 France Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 100 France Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 101 France Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 102 France Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 103 United Kingdom Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 104 United Kingdom Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 105 United Kingdom Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 106 United Kingdom Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 107 United Kingdom Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 108 United Kingdom Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 109 United Kingdom Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 110 United Kingdom Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 111 Italy Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 112 Italy Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 113 Italy Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 114 Italy Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 115 Italy Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 116 Italy Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 117 Italy Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 118 Italy Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 119 Spain Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 120 Spain Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 121 Spain Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 122 Spain Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 123 Spain Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 124 Spain Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 125 Spain Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 126 Spain Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 127 Benelux Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 128 Benelux Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 129 Benelux Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 130 Benelux Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 131 Benelux Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 132 Benelux Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 133 Benelux Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 134 Benelux Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 135 Russia Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 136 Russia Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 137 Russia Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 138 Russia Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 139 Russia Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 140 Russia Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 141 Russia Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 142 Russia Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 143 Rest of Europe Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 144 Rest of Europe Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 145 Rest of Europe Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 146 Rest of Europe Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 147 Rest of Europe Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 148 Rest of Europe Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 149 Rest of Europe Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 150 Rest of Europe Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 151 Asia Pacific Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 152 Asia Pacific Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 153 Asia Pacific Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 154 Asia Pacific Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 155 Asia Pacific Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 156 Asia Pacific Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 157 Asia Pacific Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 158 Asia Pacific Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 159 China Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 160 China Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 161 China Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 162 China Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 163 China Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 164 China Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 165 China Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 166 China Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 167 Japan Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 168 Japan Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 169 Japan Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 170 Japan Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 171 Japan Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 172 Japan Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 173 Japan Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 174 Japan Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 175 India Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 176 India Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 177 India Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 178 India Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 179 India Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 180 India Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 181 India Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 182 India Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 183 South Korea Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 184 South Korea Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 185 South Korea Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 186 South Korea Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 187 South Korea Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 188 South Korea Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 189 South Korea Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 190 South Korea Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 191 South-East Asia Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 192 South-East Asia Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 193 South-East Asia Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 194 South-East Asia Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 195 South-East Asia Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 196 South-East Asia Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 197 South-East Asia Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 198 South-East Asia Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 199 Rest of Asia Pacific Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 200 Rest of Asia Pacific Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 201 Rest of Asia Pacific Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 202 Rest of Asia Pacific Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 203 Rest of Asia Pacific Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 204 Rest of Asia Pacific Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 205 Rest of Asia Pacific Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 206 Rest of Asia Pacific Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 207 Latin America Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 208 Latin America Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 209 Latin America Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 210 Latin America Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 211 Latin America Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 212 Latin America Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 213 Latin America Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 214 Latin America Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 215 Brazil Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 216 Brazil Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 217 Brazil Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 218 Brazil Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 219 Brazil Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 220 Brazil Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 221 Brazil Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 222 Brazil Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 223 Argentina Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 224 Argentina Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 225 Argentina Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 226 Argentina Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 227 Argentina Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 228 Argentina Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 229 Argentina Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 230 Argentina Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 231 Rest of Latin America Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 232 Rest of Latin America Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 233 Rest of Latin America Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 234 Rest of Latin America Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 235 Rest of Latin America Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 236 Rest of Latin America Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 237 Rest of Latin America Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 238 Rest of Latin America Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 239 Middle East Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 240 Middle East Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 241 Middle East Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 242 Middle East Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 243 Middle East Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 244 Middle East Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 245 Middle East Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 246 Middle East Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 247 UAE Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 248 UAE Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 249 UAE Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 250 UAE Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 251 UAE Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 252 UAE Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 253 UAE Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 254 UAE Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 255 Saudi Arabia Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 256 Saudi Arabia Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 257 Saudi Arabia Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 258 Saudi Arabia Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 259 Saudi Arabia Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 260 Saudi Arabia Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 261 Saudi Arabia Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 262 Saudi Arabia Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 263 Rest of Middle East Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 264 Rest of Middle East Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 265 Rest of Middle East Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 266 Rest of Middle East Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 267 Rest of Middle East Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 268 Rest of Middle East Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 269 Rest of Middle East Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 270 Rest of Middle East Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 271 Africa Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 272 Africa Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 273 Africa Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 274 Africa Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 275 Africa Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 276 Africa Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 277 Africa Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 278 Africa Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 279 South Africa Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 280 South Africa Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 281 South Africa Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 282 South Africa Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 283 South Africa Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 284 South Africa Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 285 South Africa Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 286 South Africa Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 287 Egypt Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 288 Egypt Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 289 Egypt Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 290 Egypt Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 291 Egypt Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 292 Egypt Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 293 Egypt Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 294 Egypt Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)
TABLE 295 Rest of Africa Compounding Pharmacies Market, By Type of Compounding, 2017-2022 (US$ Mn)
TABLE 296 Rest of Africa Compounding Pharmacies Market, By Type of Compounding, 2023-2030 (US$ Mn)
TABLE 297 Rest of Africa Compounding Pharmacies Market, By End-User, 2017-2022 (US$ Mn)
TABLE 298 Rest of Africa Compounding Pharmacies Market, By End-User, 2023-2030 (US$ Mn)
TABLE 299 Rest of Africa Compounding Pharmacies Market, By Medication Type, 2017-2022 (US$ Mn)
TABLE 300 Rest of Africa Compounding Pharmacies Market, By Medication Type, 2023-2030 (US$ Mn)
TABLE 301 Rest of Africa Compounding Pharmacies Market, By Regulatory Environment, By Region, 2017-2022 (US$ Mn)
TABLE 302 Rest of Africa Compounding Pharmacies Market, By Regulatory Environment, By Region, 2023-2030 (US$ Mn)

Frequently Asked Questions

What is the current Species of the worldwide Compounding Pharmacies Market?

In 2022, the global Compounding Pharmacies Market is expected to be worth USD 13154.8 million.

What is the predicted growth rate of the Compounding Pharmacies Market between 2023 and 2030?

The Compounding Pharmacies Market is estimated to increase at a CAGR of 5.50% between 2023 and 2030, reaching USD 20188.4 Million in 2030.

Which segment has the most market share in terms of types of compounding ?

The sterility sector had the largest market share in 2022

Which regulatory environment  segment governs the market demand for Compounding Pharmacies?

The Compounding Pharmacies market is dominated by the Regulated Compounding sector

Which end-user segment is predicted to grow at the fastest growing segment over the forecast period?

The Hospitals and Healthcare Facilities sector is the fastest growing in the Compounding Pharmacies market

Which region is driving the Compounding Pharmacies industry forward?

North America held the most share (43.56%) in 2022

Who are the major players in the global Compounding Pharmacies Market?

The top players include Galderma S.A., Allergan PLC, Merz Pharma, Laboratory ObvieLine, Bausch Health Companies Inc., La Roche-Posay, IMAGE SKINCARE, Glytone, Lasermed, SciVision Biotech Inc.

What are the major market drivers of the Compounding Pharmacies industry?

The primary drivers of the market are rising demand for tailored treatments, advancements in pharmaceutical compounding procedures, and the rising prevalence of chronic diseases.

What are the major market restraints of the Compounding Pharmacies industry?

The significant obstacles in the market are stringent regulatory requirements, limited insurance coverage for compounded drugs, and difficulties in maintaining quality control and uniformity.

What are the major market opportunities of the Compounding Pharmacies industry?

The aging population, the expansion of compounded services in emerging nations, and  Collaborations and collaborations with healthcare providers and pharmaceutical companies are the market’s most promising opportunities.

Antineoplastic Agents Market

Published:
Report ID: 36065

US Retail Pharmacy Market

Published:
Report ID: 32801

OTC Vitamins Dietary Supplements Market

Published:
Report ID: 35994

Liposomes Market

Published:
Report ID: 35888

UK Iron Supplement Market

Published:
Report ID: 35709

U.S. Iron Supplement Market

Published:
Report ID: 35688

Malignant Ascites Market

Published:
Report ID: 11184

Middle East and Africa In-Vitro Fertilization (IVF) Market

Published:
Report ID: 35578

Chronic Myeloid Leukemia (CML) Treatment Market

Published:
Report ID: 2939

Combination Therapies In Aesthetics Market

Published:
Report ID: 35434

CAR T-Cell Therapy Market

Published:
Report ID: 2051

OTC Cough Cold And Allergy Medicine Market

Published:
Report ID: 20062

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN